citrulline has been researched along with ACD-MPV in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Datar, SA; Fineman, JR; Oishi, P | 1 |
Bazyk, A; Christman, BW; Dawling, S; Haines, JL; Pearson, DL; Scott, N; Summar, ML; Walsh, WF | 1 |
1 review(s) available for citrulline and ACD-MPV
Article | Year |
---|---|
Advances in the management of pediatric pulmonary hypertension.
Topics: Animals; Antihypertensive Agents; Bosentan; Child; Citrulline; Drug Therapy, Combination; Endothelium, Vascular; Hemodynamics; Humans; Hypertension, Pulmonary; Infant; Infant, Newborn; Muscle Contraction; Persistent Fetal Circulation Syndrome; Phosphodiesterase 5 Inhibitors; Piperazines; PPAR gamma; Prostaglandins; Purines; Sildenafil Citrate; Sulfonamides; Sulfones; Vascular Resistance; Vasoconstriction; Ventricular Function, Right | 2011 |
1 other study(ies) available for citrulline and ACD-MPV
Article | Year |
---|---|
Neonatal pulmonary hypertension--urea-cycle intermediates, nitric oxide production, and carbamoyl-phosphate synthetase function.
Topics: Arginine; Carbon-Nitrogen Ligases with Glutamine as Amide-N-Donor; Case-Control Studies; Citrulline; Female; Genetics, Population; Genotype; Humans; Infant, Newborn; Male; Nitric Oxide; Persistent Fetal Circulation Syndrome; Polymorphism, Genetic; Urea | 2001 |